4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-23-000094
Chief Medical Officer acquired 5,018 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2023-12-11 | Option exercise | +5,018 | $0.54 | $2,710 | 20,069 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2023-12-11 | Option exercise · Stock Option | −5,018 | 65,224 | D | ||
Loading xslF345X05/wk-form4_1702418911.xml…